
Kimberly-Clark (KMB) Stock Forecast & Price Target
Kimberly-Clark (KMB) Analyst Ratings
Bulls say
Kimberly-Clark is positioned as a leading manufacturer in the tissue and hygiene industry, deriving over half of its sales from personal care products and a significant portion from consumer tissue, with strong brand presence through products like Huggies, Kleenex, and Depend. The company is focused on enhancing innovation and anticipates a robust pipeline in 2026, which supports its ability to introduce improved products and technologies, thereby potentially increasing market share. Moreover, with sales distribution primarily in North America, Europe, and expanding efforts in Asia and Latin America, alongside plans to integrate Kenvue's consumer health portfolio, Kimberly-Clark is strategically set to leverage its diversified markets and product offerings for future growth.
Bears say
Kimberly-Clark is facing a concerning trend with an estimated -4.0% organic sales decline in North America for the third quarter of 2025, markedly lower than the previous expectation of +4.5%. Furthermore, the company has reported a -2.7% decline in measured retail sales in the U.S. for the third quarter of 2025 year-to-date. In response to these challenges, the firm has revised its earnings per share (EPS) estimates downward, reducing the forecasts for fiscal 2025 from $7.60 to $7.41 and for 2026 from $8.00 to $7.85.
This aggregate rating is based on analysts' research of Kimberly-Clark and is not a guaranteed prediction by Public.com or investment advice.
Kimberly-Clark (KMB) Analyst Forecast & Price Prediction
Start investing in Kimberly-Clark (KMB)
Order type
Buy in
Order amount
Est. shares
0 shares